April 16th 2024
The FDA has released guidelines for clinicians and tips to identify the distinguishing features of counterfeit products.
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Dermatologists steer clear of in-office surgical mishaps
April 1st 2002New Orleans - The reality of the circumstances surrounding deaths and injuries among patients undergoing office-based surgery is much different from the media portrayal of those events and raises questions about medical board and government regulations aiming to limit the procedures, Brett Coldiron, M.D., said at the annual meeting of the American Academy of Dermatology.
Role of intralesional photocoagulation still cloudy
April 1st 2002New Orleans - Surface treatment with a 1064nm Nd:YAG laser has established value in the management of bleeding vascular birthmarks, but the exact role of intralesional photocoagulation with the laser has yet to be determined, Moise L. Levy, M.D., said at the annual meeting of the American Academy of Dermatology.
Pulsed dye laser option for lesions of lupus
April 1st 2002New Orleans - The pulsed dye laser is a good alternative for treating active cutaneous lesions of lupus having a prominent erythematous component, dermatologists from Madrid's University of Alcala said at the annual meeting of the American Academy of Dermatology.
MF remains diagnosis, treatment challenge
April 1st 2002New Orleans - Even with fairly recent advances in the testing and treatment of mycosis fungoides, difficulties still remain with the diagnosis of the rare, slowly progressing cutaneous lymphoma, David P. Fivenson, M.D., said at the annual meeting of the American Academy of Dermatology.
BCC risk in rhinophyma patients should be taken into account
April 1st 2002New Orleans - Rhinophyma resection needs to be performed in a way that allows for postoperative histopathologic study, according to Luis A. Lopardo, MD, speaking here at the 60th annual meeting of the American Academy of Dermatology.
Trial compares responses to BTX-A, BTX-B
March 1st 2002New Orleans - Results of a preliminary, double-blind, parallel group study demonstrate the efficacy of botulinum toxin type A (BTX-A, Botox) 20 units and botulinum toxin type B (BTX-B, Myobloc) 1,000 and 2,000 units for correcting deep glabellar furrows.
Topical tacrolimus improves vitiligo; adding sunlight may help even more
March 1st 2002New Orleans - Results from an exploratory study indicate a potential role for topical tacrolimus in the management of vitiligo, Emil A. Tanghetti, M.D., said at the annual meeting of the American Academy of Dermatology.
Calcium alginate dressing closes cancer defects
March 1st 2002New Orleans - Second intention healing with a calcium alginate dressing can be a useful alternative for closing skin-cancer excision facial defects in select patients who might otherwise be managed with primary closure, local flaps, or skin grafts, Roger H. Weenig, M.D., M.P.H., said at the annual meeting of the American Academy of Dermatology.
The evolution of cosmetic surgery for the common good
February 1st 2002There exists today with both the lay public and some physicians a significantmisunderstanding about who is qualified to perform cosmetic or aestheticsurgical procedures. Perhaps this is the proper time to try and correctsome of the more common misimpressions about this controversy.